For help on how to get the results you want, see our search tips.
45 results
Medicine
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Referrals Remove Referrals filter
Referral type
Article 35 Remove Article 35 filter
-
List item
Referral: Colistin
Colistin sulfate, Article 35
Status: European Commission final decision, opinion/position date: 10/02/2010, EC decision date: 10/06/2010, Last updated: 24/06/2010 -
List item
Referral: Ivermectin
ivermectin, Article 35
Status: European Commission final decision, opinion/position date: 05/06/2009, EC decision date: 01/10/2009, Last updated: 26/10/2009 -
List item
Referral: Sodium Salicylate
sodium salicylate, Article 35
Status: European Commission final decision, opinion/position date: 16/07/2008, EC decision date: 26/09/2008, Last updated: 19/11/2008 -
List item
Referral: Suramox 15 % LA and its associated name Stabox 15 % LA
amoxicillin, associated names: Stabox 15% LA, Article 35
Status: European Commission final decision, opinion/position date: 18/06/2008, EC decision date: 05/09/2008, Last updated: 15/10/2008 -
List item
Referral: Tribrissen
trimethoprim, sulfadiazine, Article 35
Status: European Commission final decision, opinion/position date: 12/12/2007, EC decision date: 11/03/2008, Last updated: 09/10/2008 -
List item
Referral: Toltrazuril
toltrazuril, Article 35
Status: European Commission final decision, opinion/position date: 16/07/2008, EC decision date: 26/09/2008, Last updated: 26/07/2008 -
List item
Referral: Suramox
amoxicillin, Article 35
Status: European Commission final decision, opinion/position date: 14/03/2007, EC decision date: 13/06/2007, Last updated: 25/07/2007 -
List item
Referral: Gentamicin
gentamicin, Article 35
Status: European Commission final decision, opinion/position date: 06/11/2014, EC decision date: 11/02/2015, Last updated: 10/04/2015 -
List item
Referral: Closantel
closantel, Article 35
Status: European Commission final decision, opinion/position date: 21/02/2019, EC decision date: 20/05/2019, Last updated: 27/06/2019 -
List item
Referral: Veterinary medicinal products containing tylosin presented as solution for injection to be administered to sheep
tylosin, associated names: See annex I, Article 35
Status: European Commission final decision, opinion/position date: 20/06/2019, EC decision date: 20/09/2019, Last updated: 19/11/2019 -
List item
Referral: Veterinary medicinal products containing paromomycin to be administered parenterally to pigs
paromycin, associated names: Parofor, Gabbrovet, Gabbrocol, Article 35
Status: European Commission final decision, opinion/position date: 18/07/2019, EC decision date: 11/10/2019, Last updated: 20/11/2019 -
List item
Referral: Veterinary medicinal products containing tylosin base (as a single active substance) presented as solutions for injection for intramuscular use in pigs
tylosin, Article 35
Status: European Commission final decision, opinion/position date: 05/12/2019, EC decision date: 17/04/2020, Last updated: 13/05/2020 -
List item
Referral: Dinolytic 12.5 mg/ml and 5 mg/ml solutions for injection and associated names, and generic products thereof
dinoprost, Article 35
Status: European Commission final decision, opinion/position date: 18/06/2020, EC decision date: 16/09/2020, Last updated: 06/10/2020 -
List item
Referral: Stresnil 40 mg/ml solution for injection for pigs and associated names, and generic products thereof
azaperone, Article 35
Status: European Commission final decision, opinion/position date: 16/07/2020, EC decision date: 12/10/2020, Last updated: 30/10/2020 -
List item
Referral: Betamox LA 150 mg/ml suspension for injection and associated names, and generics products thereof
Amoxicillin trihydrate, Article 35
Status: European Commission final decision, opinion/position date: 16/07/2020, EC decision date: 12/10/2020, Last updated: 12/11/2020 -
List item
Referral: Tiamulin hydrogen fumarate presented as premix for medicated feeding stuff and oral powder for in-feed use to be administered to pigs
tiamulin hydrogen fumarate, Article 35
Status: European Commission final decision, opinion/position date: 09/09/2020, EC decision date: 09/12/2020, Last updated: 05/02/2021 -
List item
Referral: Valbazen 100 mg/ml Total Spectrum Wormer oral suspension and associated names, including its generic/hybrid products
albendazole, Article 35
Status: European Commission final decision, opinion/position date: 05/11/2020, EC decision date: 18/01/2021, Last updated: 22/02/2021 -
List item
Referral: Modified live porcine respiratory and reproductive syndrome (PRRS) virus vaccines
Porcine respiratory and reproductive syndrome virus vaccine (live), associated names: See annex I, Article 35
Status: European Commission final decision, opinion/position date: 15/04/2021, EC decision date: 13/07/2021, Last updated: 28/07/2021 -
List item
Referral: Injectable veterinary medicinal products containing vitamin A for use in food producing species
Vitamin A (retinol and its esters), Article 35
Status: European Commission final decision, opinion/position date: 12/05/2021, EC decision date: 18/08/2021, Last updated: 27/09/2021 -
List item
Referral: Veterinary medicinal products containing toltrazuril to be administered orally to chickens
toltrazuril, Article 35
Status: European Commission final decision, opinion/position date: 14/07/2022, EC decision date: 09/11/2022, Last updated: 14/12/2022